Cost Analysis of High-Flow Oxygen Therapy Compared with Conventional Oxygen Therapy in Severe COVID-19 in Colombia: Data from a Randomized Clinical Trial

References

• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. PMID: 32091533. doi:10.1001/jama.2020.2648
   PubMed Web of Science ®Google Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/jama.2020.5394
   PubMed Web of Science ®Google Scholar
• Rosselli D. COVID-19 in Colombia: the first 90 days. Acta Neurol Colomb. 2020;36(1):1–6. doi:10.22379/24224022287
   Google Scholar
• Lee CC, Mankodi D, Shaharyar S, et al. High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: a systematic review. Respir Med. 2016;121:100–108. doi:10.1016/j.rmed.2016.11.004
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. doi:10.1001/jama.2020.6775
   PubMed Web of Science ®Google Scholar
• Tobin MJ. Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med. 2020;201(11):1319–1320. doi:10.1164/rccm.202004-1076ED
   PubMed Web of Science ®Google Scholar
• Lebreton G, Schmidt M, Ponnaiah M, et al. Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study. Lancet Respir Med. 2021;9(8):851–862. doi:10.1016/S2213-2600(21)00096-5
   PubMed Web of Science ®Google Scholar
• Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the International Extracorporeal Life Support Organization Registry. Lancet. 2021;398(10307):1230–1238. doi:10.1016/S0140-6736(21)01960-7
   PubMed Web of Science ®Google Scholar
• Demoule A, Vieillard Baron A, Darmon M, et al. High-flow nasal cannula in critically ill patients with severe COVID-19. Am J Respir Crit Care Med. 2020;202(7):1039–1042. doi:10.1164/rccm.202005-2007LE
   PubMed Web of Science ®Google Scholar
• Mauri T, Turrini C, Eronia N, et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1207–1215. doi:10.1164/rccm.201605-0916OC
   PubMed Web of Science ®Google Scholar
• Mauri T, Alban L, Turrini C, et al. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med. 2017;43(10):1453–1463. doi:10.1007/s00134-017-4890-1
   PubMed Web of Science ®Google Scholar
• Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185–2196. doi:10.1056/NEJMoa1503326
   PubMed Web of Science ®Google Scholar
• Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med. 2019;45(8):563–572. doi:10.1007/s00134-019-05590-5
   PubMed Web of Science ®Google Scholar
• Ni YN, Luo J, Yu H, et al. Can high-flow nasal cannula reduce the rate of endotracheal intubation in adult patients with acute respiratory failure compared with conventional oxygen therapy and noninvasive positive pressure ventilation? A systematic review and meta-analysis. Chest. 2017;151(4):764–775. doi:10.1016/j.chest.2017.01.004
   PubMed Web of Science ®Google Scholar
• Ou X, Hua Y, Liu J, Gong C, Zhao W. Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials. CMAJ. 2017;189(7):E260–E267. doi:10.1503/cmaj.160570
   PubMed Web of Science ®Google Scholar
• Mellado-Artigas R, Ferreyro BL, Angriman F, et al. High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure. Crit Care. 2021;25(1):58. doi:10.1186/s13054-021-03469-w
   PubMed Web of Science ®Google Scholar
• Ospina-Tascón GA, Calderón-Tapia LE, García AF, et al. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA. 2021;326(21):2161–2171. doi:10.1001/jama.2021.20714
   PubMed Web of Science ®Google Scholar
• Frat JP, Quenot JP, Badie J, et al. Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: the SOHO-COVID randomized clinical trial. JAMA. 2022;328(12):1212–1222. doi:10.1001/jama.2022.15613
   PubMed Web of Science ®Google Scholar
• Paraskevas T, Oikonomou E, Lagadinou M, et al. The role of high flow nasal oxygen in the management of severe COVID-19: a systematic review. Acta Med Port. 2022;35(6):476–483. doi:10.20344/amp.16686
   PubMed Web of Science ®Google Scholar
• Eaton Turner E, Jenks M. Cost-effectiveness analysis of the use of high-flow oxygen through nasal cannula in intensive care units in NHS England. Expert Rev Pharmacoecon Outcomes Res. 2018;18(3):331–337. doi:10.1080/14737167.2018.1411804
   PubMed Web of Science ®Google Scholar
• Fealy N, Osborne C, Eastwood GM, Glassford N, Hart G, Bellomo R. Nasal high-flow oxygen therapy in ICU: a before-and-after study. Aust Crit Care. 2016;29(1):17–22. doi:10.1016/j.aucc.2015.05.003
   PubMed Web of Science ®Google Scholar
• Echeverri ED, Ruiz-Morales AJ, Rondon M, Rosselli D. Una aproximación a la distribución de los costos directos de la diabetes tipo 2 en Colombia. Salud Pública Méx. 2022;64(5):449–450. doi:10.21149/13822
   PubMedGoogle Scholar